These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28322982)

  • 1. Toward biomarkers of the addicted human brain: Using neuroimaging to predict relapse and sustained abstinence in substance use disorder.
    Moeller SJ; Paulus MP
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):143-154. PubMed ID: 28322982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional brain recovery in individuals with substance use disorders during abstinence: A review of longitudinal neuroimaging studies.
    Parvaz MA; Rabin RA; Adams F; Goldstein RZ
    Drug Alcohol Depend; 2022 Mar; 232():109319. PubMed ID: 35077955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining gray matter volume in the cuneus and the cuneus-prefrontal connectivity may predict early relapse in abstinent alcohol-dependent patients.
    Wang J; Fan Y; Dong Y; Ma M; Dong Y; Niu Y; Jiang Y; Wang H; Wang Z; Wu L; Sun H; Cui C
    PLoS One; 2018; 13(5):e0196860. PubMed ID: 29734343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional cerebral blood flow predictors of relapse and resilience in substance use recovery: A coordinate-based meta-analysis of human neuroimaging studies.
    Forster SE; Dickey MW; Forman SD
    Drug Alcohol Depend; 2018 Apr; 185():93-105. PubMed ID: 29428325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse.
    Gowin JL; Ball TM; Wittmann M; Tapert SF; Paulus MP
    Drug Alcohol Depend; 2015 Jul; 152():93-101. PubMed ID: 25977206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Volume Correlates with Duration of Abstinence from Substance Abuse in a Region-Specific and Substance-Specific Manner.
    Korponay C; Kosson DS; Decety J; Kiehl KA; Koenigs M
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Oct; 2(7):626-635. PubMed ID: 29308437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroscience of inhibition for addiction medicine: from prediction of initiation to prediction of relapse.
    Moeller SJ; Bederson L; Alia-Klein N; Goldstein RZ
    Prog Brain Res; 2016; 223():165-88. PubMed ID: 26806776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for Success: Using Neuroimaging to Predict Relapse and Develop Brain Stimulation Treatments for Cocaine-Dependent Individuals.
    Hanlon CA; Dowdle LT; Jones JL
    Int Rev Neurobiol; 2016; 129():125-56. PubMed ID: 27503451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal gray matter volume and resting-state functional connectivity in former heroin-dependent individuals abstinent for multiple years.
    Wang L; Zou F; Zhai T; Lei Y; Tan S; Jin X; Ye E; Shao Y; Yang Y; Yang Z
    Addict Biol; 2016 May; 21(3):646-56. PubMed ID: 25727574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural Underpinnings of Social Stress in Substance Use Disorders.
    Sahani V; Hurd YL; Bachi K
    Curr Top Behav Neurosci; 2022; 54():483-515. PubMed ID: 34971448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.
    Lener MS; Iosifescu DV
    Ann N Y Acad Sci; 2015 May; 1344():50-65. PubMed ID: 25854817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cigarette smoking is linked with structural alterations in brain regions showing acute nicotinic drug-induced functional modulations.
    Sutherland MT; Riedel MC; Flannery JS; Yanes JA; Fox PT; Stein EA; Laird AR
    Behav Brain Funct; 2016 Jun; 12(1):16. PubMed ID: 27251183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities and Differences in Neuroimaging.
    Sun YK; Sun Y; Lin X; Lu L; Shi J
    Adv Exp Med Biol; 2017; 1010():73-89. PubMed ID: 29098669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging in drug abuse.
    Lindsey KP; Gatley SJ; Volkow ND
    Curr Psychiatry Rep; 2003 Oct; 5(5):355-61. PubMed ID: 13678555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity.
    Moeller SJ; London ED; Northoff G
    Neurosci Biobehav Rev; 2016 Feb; 61():35-52. PubMed ID: 26657968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients.
    Beck A; Wüstenberg T; Genauck A; Wrase J; Schlagenhauf F; Smolka MN; Mann K; Heinz A
    Arch Gen Psychiatry; 2012 Aug; 69(8):842-52. PubMed ID: 22868938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning with neuroimaging biomarkers: Application in the diagnosis and prediction of drug addiction.
    Yang L; Du Y; Yang W; Liu J
    Addict Biol; 2023 Feb; 28(2):e13267. PubMed ID: 36692873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol and the human brain: a systematic review of different neuroimaging methods.
    Bühler M; Mann K
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1771-93. PubMed ID: 21777260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging for addiction medicine: From neural mechanisms to clinical considerations.
    Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ
    Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder.
    Uddin LQ; Dajani DR; Voorhies W; Bednarz H; Kana RK
    Transl Psychiatry; 2017 Aug; 7(8):e1218. PubMed ID: 28892073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.